Impact of TP53 status on the metabolic activation of environmental carcinogens

被引：0

作者：

Wohak, Laura U. E. ^{[1
,2
]}

Seidel, Albrecht ^{[3
]}

Phillips, David H. ^{[2
]}

Arlt, Volker M. ^{[2
]}

机构：

[1] Inst Canc Res, Sutton, Surrey, England

[2] Kings Coll London, London WC2R 2LS, England

[3] Inst Environm Carcinogens, Grosshansdorf, Germany

来源：

MUTAGENESIS | 2012年 / 27卷 / 06期

关键词：

D O I：

暂无

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：803 / 804

页数：2

共 50 条

[41] TP53 Action and the Consequences of TP53 Mutation in Acute Myeloid Leukemia [J].

Lowe, Scott W. .

BLOOD, 2019, 134

[42] Impact of TP53 polymorphisms (IVS3 [J].

Nagam, Srivani L. S. S. ;

Jinka, Rajeswari .

META GENE, 2020, 24

[43] ASSESSMENT OF IMPACT OF TP53 IN DIFFERENT HAEMATOLOGICAL NEOPLASIAS [J].

de Lacalle Juega, Lopez A. ;

Cedena Romero, M. T. ;

Ayala Diaz, R. ;

Martinez Lopez, J. ;

Gilsanz Rodriguez, F. .

HAEMATOLOGICA, 2015, 100 :81-82

[44] Is TP53 Mutated AML the Same Disease as TP53 Mutated MDS? [J].

Valk, Peter J. M. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 :S3-S5

[45] Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway [J].

Saba, Karim H. ;

Difilippo, Valeria ;

Kovac, Michal ;

Cornmark, Louise ;

Magnusson, Linda ;

Nilsson, Jenny ;

van den Bos, Hilda ;

Spierings, Diana C. J. ;

Bidgoli, Mahtab ;

Jonson, Tord ;

Sumathi, Vaiyapuri P. ;

Brosjoe, Otte ;

Staaf, Johan ;

Foijer, Floris ;

Styring, Emelie ;

Nathrath, Michaela ;

Baumhoer, Daniel ;

Nord, Karolin H. .

JOURNAL OF PATHOLOGY, 2024, 262 (02) :147-160

[46] TP53 MUTATION STATUS IS A POTENTIAL PREDICTIVE MARKER IN MEDULLOBLASTOMA [J].

Pfaff, Elke ;

Remke, Marc ;

Sturm, Dominik ;

Witt, Hendrik ;

von Bueren, Andre O. ;

Wittmann, Andrea ;

Schoettler, Anna ;

Scheurlen, Wolfram ;

Kulozik, Andreas E. ;

Witt, Olaf ;

von Deimling, Andreas ;

Rutkowski, Stefan ;

Hawkins, Cynthia ;

Tabori, Uri ;

Lichter, Peter ;

Korshunov, Andrey ;

Pfister, Stefan M. .

PEDIATRIC BLOOD & CANCER, 2010, 55 (05) :799-799

[47] TP53 status and gene amplification in human colorectal carcinomas [J].

Soulié, P ;

Fourme, E ;

Hamelin, R ;

Asselain, B ;

Salmon, RJ ;

Dutrillaux, B ;

Muleris, M .

CANCER GENETICS AND CYTOGENETICS, 1999, 115 (02) :118-122

[48] The status of MGMT methylation and TP53 mutations in patients with glioblastoma [J].

Jesionek-Kupnicka, Dorota ;

Zawlik, Izabela ;

Jesien-Lewandowicz, Emilia ;

Szybka, Malgorzata ;

Kulczycka, Dominika ;

Kusinska, Reneta ;

Pasz-Walczak, Grazyna ;

Kordek, Radzislaw .

VIRCHOWS ARCHIV, 2007, 451 (02) :240-240

[49] Effect of TP53 mutation status on survival in the MAGIC trial [J].

Smyth, Elizabeth Catherine ;

Wilson, Sanna Hulkki ;

Nankivell, Matthew Guy ;

de Castro, David Gonzalez ;

Wotherspoon, Andrew ;

Okines, Alicia Frances Clare ;

Langley, Ruth E. ;

Stenning, Sally Patricia ;

Cunningham, David .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)

[50] Personalizing HNSCC treatment based on TP53 mutational status [J].

Myers, Jeffrey .

CLINICAL CANCER RESEARCH, 2017, 23 (23)

← 1 2 3 4 5 →